MannKind Corp
MNKD
#5812
Rank
S$1.60 B
Marketcap
S$4.99
Share price
3.72%
Change (1 day)
-29.20%
Change (1 year)

EPS for MannKind Corp (MNKD)

EPS in 2023 (TTM): S-$0.26

According to MannKind Corp's latest financial reports the company's current EPS (TTM) is S-$0.17. In 2022 the company made an earnings per share (EPS) of S-$0.44 a decrease over its 2021 EPS that were of S-$0.41.

EPS history for MannKind Corp from 2004 to 2023

Annual EPS

Year EPS Change
2023 (TTM)S-$0.26-40.22%
2022S-$0.446.25%
2021S-$0.4128%
2020S-$0.32-7.41%
2019S-$0.35-55.74%
2018S-$0.78-45.05%
2017S-$1.42-188.1%
2016S$1.61-128.31%
2015S-$5.7074.51%
2014S-$3.26-20.31%
2013S-$4.10-32.63%
2012S-$6.08-28.03%
2011S-$8.45-12%
2010S-$9.60-27.54%
2009S-$13.25-30.3%
2008S-$19.01-18.85%
2007S-$23.43-19.03%
2006S-$28.9356.94%
2005S-$18.44-21.74%
2004S-$23.56

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Pfizer
PFE
S$0.97-684.62%๐Ÿ‡บ๐Ÿ‡ธ USA
Novo Nordisk
NVO
S$5.22-3,236.63%๐Ÿ‡ฉ๐Ÿ‡ฐ Denmark
Eli Lilly
LLY
S$39.52-23,843.23%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
S$1.27-863.63%๐Ÿ‡บ๐Ÿ‡ธ USA
Halozyme Therapeutics
HALO
S$4.51-2,807.69%๐Ÿ‡บ๐Ÿ‡ธ USA
Nektar Therapeutics
NKTR
S-$3.79 2,176.92%๐Ÿ‡บ๐Ÿ‡ธ USA